Your email has been successfully added to our mailing list.

×
0 0 0.00180180180180192 0.00180180180180192 0 0.00180180180180192 0.0341621621621622 0.0486486486486487
Stock impact report

Omeros, Anavex Results Positive, Protagonist Suffers Setback: The Good, Bad, And Ugly Of Biopharma [Seeking Alpha]

Anavex Life Sciences Corp. (AVXL) 
NASDAQ:AMEX Investor Relations: anavex.com/share-data
Company Research Source: Seeking Alpha
Omeros, Anavex Results Positive, Protagonist Suffers Setback: The Good, Bad, And Ugly Of Biopharma Summary OMS721 showed positive data in pivotal study; however, now, we also have a secondary offering. Anavex came up with positive phase 2a extension data. Investors seem disappointed with Protagonist data. Omeros (NASDAQ: OMER assessments Primary efficacy endpoint Secondary endpoints There were other improvements in various metrics like platelet count, LDH, haptoglobin, improvements in hemoglobin and creatinine across all groups as well as across complete responders. Safety signals were good. There were no treatment-related deaths; in the phase 2 trial, there was one death out of 9 total deaths which could not be ruled out as not being treatment-related. Earlier this year, we wrote a bullish article on OMER; this followed a set of articles we wrote in the years before that. Omeros has an approved drug called OMIDRIA which is generating a stream of revenue; however, OMS721 has always Show less Read more
Impact Snapshot
Event Time:
AVXL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for
AVXL alerts

from News Quantified
Opt-in for
AVXL alerts

from News Quantified